C. Wageman

发表

Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release

M. Marks, S. Grady, C. Wageman, 2012, Neuropharmacology.

Structural differences determine the relative selectivity of nicotinic compounds for native α4β2*-, α6β2*-, α3β4*- and α7-nicotine acetylcholine receptors

H. Lester, M. Bencherif, S. R. Breining, 2010, Neuropharmacology.

Developmental nicotine exposure precipitates multigenerational maternal transmission of nicotine preference and ADHD-like behavioral, rhythmometric, neuropharmacological, and epigenetic anomalies in adolescent mice

J. Stitzel, V. Knopik, C. Wageman, 2019, Neuropharmacology.

Abstract 2116: Combining the power of different profiling approaches to better understand the activity of kinase inhibitor drugs

U. Warrior, A. King, S. Davies, 2017 .

Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.

M. Marks, S. Mascarella, H. Navarro, 2016, ACS chemical neuroscience.

α6β2*‐subtype nicotinic acetylcholine receptors are more sensitive than α4β2*‐subtype receptors to regulation by chronic nicotine administration

M. Marks, S. Grady, J. McIntosh, 2014, Journal of neurochemistry.

In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.

M. Marks, S. Mascarella, H. Navarro, 2015, ACS chemical neuroscience.

Nicotinic Acetylcholine Receptor Expression and Function in a Visual Salience Circuit

H. Lester, M. Marks, S. Grady, 2012 .

Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the alpha6( *) subtype.

H. Lester, M. Bencherif, S. R. Breining, 2009, Bioorganic & medicinal chemistry letters.

TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors

H. Lester, M. Bencherif, P. Kenny, 2017, Front. Pharmacol..

Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.

Murali Gopalakrishnan, C. Briggs, M. Marks, 2009, Biochemical pharmacology.

The interaction of the Chrna5 D398N variant with developmental nicotine exposure

M. Marks, S. Grady, J. Stitzel, 2018, Genes, brain, and behavior.

Effectiveness of nicotinic agonists as desensitizers at presynaptic α4β2- and α4α5β2-nicotinic acetylcholine receptors.

M. Marks, S. Grady, C. Wageman, 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior

H. Lester, M. Marks, S. Grady, 2012, Neuroscience.

Selectivity of ABT-089 for α 4 β 2* and α 6 β 2* nicotinic acetylcholine receptors in brain

C. Briggs, M. Marks, S. Grady, 2009 .

CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation

M. Zoli, M. Marks, C. Gotti, 2013, British journal of pharmacology.

A novel α‐conotoxin MII‐sensitive nicotinic acetylcholine receptor modulates [3H]‐GABA release in the superficial layers of the mouse superior colliculus

A. C. Collins, A. Collins, M. Marks, 2012, Journal of neurochemistry.